Reply to correspondence: “The effectiveness of pollen allergen immunotherapy on allergic rhinitis over 18 years: A national cohort study in Denmark”
Allergy · 2024
DOI: 10.1111/all.16312 ↗Kurz gefasst
Leserbrief in der Zeitschrift Allergy, 2024. Verfasst von Peter Bager und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Desensitization, Immunologic, Pollen, Rhinitis, Allergic, Seasonal. Die Arbeit nennt 2 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
- Danish Cancer Institute, Copenhagen, Denmark.
- Department of Pediatrics, Stanford University School of Medicine, Palo Alto, California, USA.
- Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
- K.G. Jebsen Center for Genetic Epidemiology, Norwegian University of Science and Technology, Trondheim, Norway.
ORCID-Profile: Peter Bager
Zitieren
APA
Bager, P., Wohlfahrt, J., & Melbye, M. (2024). Reply to correspondence: “The effectiveness of pollen allergen immunotherapy on allergic rhinitis over 18 years: A national cohort study in Denmark”. Allergy. https://doi.org/10.1111/all.16312
Vancouver
Bager P, Wohlfahrt J, Melbye M. Reply to correspondence: “The effectiveness of pollen allergen immunotherapy on allergic rhinitis over 18 years: A national cohort study in Denmark”. Allergy. 2024. doi:10.1111/all.16312
BibTeX
@article{Bager2024,
author = {Bager, Peter and Wohlfahrt, Jan and Melbye, Mads},
title = {Reply to correspondence: “The effectiveness of pollen allergen immunotherapy on allergic rhinitis over 18 years: A national cohort study in Denmark”},
journal = {Allergy},
year = {2024},
doi = {10.1111/all.16312}
}
EUVIMED